Digital Therapeutics Market Poised for Severe Growth

Digital Therapeutics, which use software systems like video games to treat medical disorders, has gone from being largely hypothetical to FDA-approved therapies in the last few years. As a tech, pharma, and Medtech companies realize their potential, the sector has seen a surge in interest and research.

Digital Therapeutics would become more advanced and available when next-generation technology such as augmented reality (AR), virtual reality (VR), artificial intelligence (AI), Cloud computing, and 5G become more widely adopted. To avoid being left behind, medical device manufacturers will need to figure out how to integrate their hardware with upcoming therapeutic software.

Digital Therapeutics is a new area that uses software applications and video games to provide evidence-based therapies for a variety of medical conditions. Researchers have been investigating the use of Digital Therapeutics in treating psychiatric illnesses like depression, schizophrenia, and dementia, as well as cardiovascular diseases, addictions, and more, in this area over the last few years.

The FDA, for example, recently approved EndeavorRx, an iOS video game that has been shown to increase objective focus in children with attention deficit hyperactivity disorder (ADHD). The player’s goal in the game is to guide a vehicle through a path while collecting a particular object and ignoring others. Many of the Digital Therapeutics under investigation provide behavioral training or adjustment.

Such therapies will become more complex, advanced, and affordable thanks to next-generation technologies. AR and VR would enable patients to immerse themselves more fully in the digital world, potentially amplifying the treatment’s effects. Since processing can be performed in the cloud and sent to several devices.